These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 26915677)

  • 21. Basophil activation test for inhalant allergens in pediatric patients with allergic rhinitis.
    Ogulur I; Kiykim A; Baris S; Ozen A; Yuce EG; Karakoc-Aydiner E
    Int J Pediatr Otorhinolaryngol; 2017 Jun; 97():197-201. PubMed ID: 28483235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical efficacy and pharmacokinetic profiles of intranasal and oral cetirizine in a repeated allergen challenge model of allergic rhinitis.
    Korsgren M; Andersson M; Borgå O; Larsson L; Aldén-Raboisson M; Malmqvist U; Greiff L
    Ann Allergy Asthma Immunol; 2007 Apr; 98(4):316-21. PubMed ID: 17458426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and tolerability of intranasally applied dimetindene maleate solution versus placebo in the treatment of seasonal allergic rhinitis.
    Horak F; Unkauf M; Beckers C; Mittermaier EM
    Arzneimittelforschung; 2000 Dec; 50(12):1099-105. PubMed ID: 11190775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of fluticasone furoate 110 microg once daily in the treatment of nasal and ocular symptoms of seasonal allergic rhinitis in adults and adolescents sensitized to mountain cedar pollen.
    Jacobs R; Martin B; Hampel F; Toler W; Ellsworth A; Philpot E
    Curr Med Res Opin; 2009 Jun; 25(6):1393-401. PubMed ID: 19419338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Onset and dose-related efficacy of house dust mite sublingual immunotherapy tablets in an environmental exposure chamber.
    Nolte H; Maloney J; Nelson HS; Bernstein DI; Lu S; Li Z; Kaur A; Zieglmayer P; Zieglmayer R; Lemell P; Horak F
    J Allergy Clin Immunol; 2015 Jun; 135(6):1494-501.e6. PubMed ID: 25636947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intranasal fluticasone propionate inhibits recovery of chemokines and other cytokines in nasal secretions in allergen-induced rhinitis.
    Weido AJ; Reece LM; Alam R; Cook CK; Sim TC
    Ann Allergy Asthma Immunol; 1996 Nov; 77(5):407-15. PubMed ID: 8933780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Passive Prophylactic Administration with a Single Dose of Anti-Fel d 1 Monoclonal Antibodies REGN1908-1909 in Cat Allergen-induced Allergic Rhinitis: A Randomized, Double-Blind, Placebo-controlled Clinical Trial.
    Shamji MH; Singh I; Layhadi JA; Ito C; Karamani A; Kouser L; Sharif H; Tang J; Handijiev S; Parkin RV; Durham SR; Kostic A; Orengo JM; DeVeaux M; Kamal M; Stahl N; Yancopoulos GD; Wang CQ; Radin AR
    Am J Respir Crit Care Med; 2021 Jul; 204(1):23-33. PubMed ID: 33651675
    [No Abstract]   [Full Text] [Related]  

  • 28. Azelastine nasal spray and desloratadine tablets in pollen-induced seasonal allergic rhinitis: a pharmacodynamic study of onset of action and efficacy.
    Horak F; Zieglmayer UP; Zieglmayer R; Kavina A; Marschall K; Munzel U; Petzold U
    Curr Med Res Opin; 2006 Jan; 22(1):151-7. PubMed ID: 16393441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in airway inflammation following nasal allergic challenge in patients with seasonal rhinitis.
    Bonay M; Neukirch C; Grandsaigne M; Leçon-Malas V; Ravaud P; Dehoux M; Aubier M
    Allergy; 2006 Jan; 61(1):111-8. PubMed ID: 16364165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Humoral and cellular responses to histamine and pollen allergen in a skin chamber model: effect of mizolastine.
    Michel L; Murrieta-Aguttes M; Jean-Louis F; Levy D; Dubertret L
    Ann Allergy Asthma Immunol; 2000 Jul; 85(1):64-9. PubMed ID: 10923607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of pollen blocker cream in the treatment of allergic rhinitis.
    Schwetz S; Olze H; Melchisedech S; Grigorov A; Latza R
    Arch Otolaryngol Head Neck Surg; 2004 Aug; 130(8):979-84. PubMed ID: 15313870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in basophil activation during grass-pollen sublingual immunotherapy do not correlate with clinical efficacy.
    Van Overtvelt L; Baron-Bodo V; Horiot S; Moussu H; Ricarte C; Horak F; Zieglmayer P; Zieglmayer R; Montagut A; Galvain S; de Beaumont O; Le Gall M; Moingeon P
    Allergy; 2011 Dec; 66(12):1530-7. PubMed ID: 21883279
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A proof-of-concept study of the effect of a novel H3-receptor antagonist in allergen-induced nasal congestion.
    Barchuk WT; Salapatek AM; Ge T; D'Angelo P; Liu X
    J Allergy Clin Immunol; 2013 Oct; 132(4):838-46.e1-6. PubMed ID: 23791513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Method for a homogeneous distribution of pollens in an environmental exposure chamber.
    Kenney P; Bønløkke J; Hilberg O; Ravn P; Schlünssen V; Sigsgaard T
    Clin Exp Allergy; 2016 Sep; 46(9):1176-84. PubMed ID: 27144495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The response to nasal allergen provocation with grass pollen is reduced in patients with chronic rhinosinusitis with nasal polyposis and grass sensitization.
    Calus L; Devuyst L; Van Zele T; De Ruyck N; Derycke L; Bachert C; Gevaert P
    Clin Exp Allergy; 2016 Apr; 46(4):555-63. PubMed ID: 26661927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diminished response to grass pollen allergen challenge in subjects with concurrent house dust mite allergy.
    Reinartz SM; van Ree R; Versteeg SA; Zuidmeer L; van Drunen CM; Fokkens WJ
    Rhinology; 2009 Jun; 47(2):192-8. PubMed ID: 19593978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective effect of montelukast on lower and upper respiratory tract responses to short-term cat allergen exposure.
    Perry TT; Corren J; Philip G; Kim EH; Conover-Walker MK; Malice MP; Massaad R; Dass SB; Reiss TF; Wood RA
    Ann Allergy Asthma Immunol; 2004 Nov; 93(5):431-8. PubMed ID: 15562881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood and nasal epigenetics correlate with allergic rhinitis symptom development in the environmental exposure unit.
    North ML; Jones MJ; MacIsaac JL; Morin AM; Steacy LM; Gregor A; Kobor MS; Ellis AK
    Allergy; 2018 Jan; 73(1):196-205. PubMed ID: 28755526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nasal treatment with a microemulsion reduces allergen challenge-induced symptoms and signs of allergic rhinitis.
    Andersson M; Greiff L; Wollmer P
    Acta Otolaryngol; 2008 Jun; 128(6):666-9. PubMed ID: 18568502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of olopatadine hydrochloride nasal spray 0.6% in the treatment of seasonal allergic rhinitis: a phase III, multicenter, randomized, double-blind, active- and placebo-controlled study in adolescents and adults.
    Shah SR; Nayak A; Ratner P; Roland P; Michael Wall G
    Clin Ther; 2009 Jan; 31(1):99-107. PubMed ID: 19243710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.